H Lena C van Doorn (H C van Doorn, Heleen van Doorn, Helena C van Doorn)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 33

Top Topics

Squamous Cell Carcinoma

Urinary Incontinence

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Acta obstetricia et gynecologica Scandinavica

BJOG : an international journal of obstetrics and gynaecology

This page only lists publications with an associated author ORCID identifier.

Publications

Laura D P R van Maldegem, Johanna A van der Zande, Lucy A van Werkhoven, Patricia C Ewing-Graham, Bernadette Anna Maria Heemskerk-Gerritsen, H Lena C van Doorn
Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational study. Acta obstetricia et gynecologica Scandinavica 103 (7) (2024)
M I E van Poelgeest, Kim E Kortekaas, H Lena C van Doorn, Maaike Oonk, Hans W Nijman, Ingrid A Boere, Anneke L Eerkens, Anna K L Reyners, Patricia C Ewing-Graham, Joost Bart, Tjalling Bosse, Marij J P Welters, Judith R Kroep, Sjoerd H van der Burg
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Laura D P R van Maldegem, Johanna A van der Zande, Lucy A van Werkhoven, Patricia C Ewing-Graham, Bernadette Anna Maria Heemskerk-Gerritsen, H Lena C van Doorn
Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational study. Acta obstetricia et gynecologica Scandinavica 103 (7) (2024)
Jonathan Servayge, Ester Paulien Olthof, Constantijne H Mom, Maaike A van der Aa, Hans H B Wenzel, Jacobus van der Velden, Remi A Nout, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy. Cancers 16 (3) (2024)
Jonathan Servayge, Ester Paulien Olthof, Constantijne H Mom, Maaike A van der Aa, Hans H B Wenzel, Jacobus van der Velden, Remi A Nout, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy. Cancers 16 (3) (2024)
M I E van Poelgeest, Kim E Kortekaas, H Lena C van Doorn, Maaike Oonk, Hans W Nijman, Ingrid A Boere, Anneke L Eerkens, Ann Reyners, Patricia C Ewing-Graham, Joost Bart, Tjalling Bosse, Marij J P Welters, Judith R Kroep, Sjoerd H van der Burg
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Laura D P R van Maldegem, Johanna A van der Zande, Lucy A van Werkhoven, Patricia C Ewing-Graham, Bernadette Anna Maria Heemskerk-Gerritsen, H Lena C van Doorn
Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational study. Acta obstetricia et gynecologica Scandinavica 103 (7) (2024)
Laura D P R van Maldegem, Johanna A van der Zande, Lucy A van Werkhoven, Patricia C Ewing-Graham, Bernadette Anna Maria Heemskerk-Gerritsen, H Lena C van Doorn
Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational study. Acta obstetricia et gynecologica Scandinavica 103 (7) (2024)
Laura D P R van Maldegem, Johanna A van der Zande, Lucy A van Werkhoven, Patricia C Ewing-Graham, Bernadette Anna Maria Heemskerk-Gerritsen, H Lena C van Doorn
Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational study. Acta obstetricia et gynecologica Scandinavica (2024)
Anna J M van de Sande, Romy van Baars, Margot M Koeneman, Cornelis G Gerestein, Arnold-Jan Kruse, Edith M G van Esch, Peggy J de Vos van Steenwijk, Caroline L P Muntinga, Sten Paul Willemsen, H Lena C van Doorn, Folkert van Kemenade, Heleen van Beekhuizen
Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC-2): A randomised controlled trial. BJOG : an international journal of obstetrics and gynaecology (2024)
Malika Kengsakul, Gatske M Nieuwenhuyzen-de Boer, Suwasin Udomkarnjananun, Stephen J Kerr, H Lena C van Doorn, Heleen van Beekhuizen
Clinical validation and comparison of the Comprehensive Complication Index and Clavien-Dindo classification in predicting post-operative outcomes after cytoreductive surgery in advanced ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (2) (2023)
Lara Terra, Bernadette A M Heemskerk-Gerritsen, Maarten J Beekman, Ellen Engelhardt, Marian J E Mourits, H Lena C van Doorn, Joanna A de Hullu, Constantijne H Mom, Brigitte F M Slangen, Katja N Gaarenstroom, Marc van Beurden, Jeanine E Roeters Van Lennep, Eleonora B L van Dorst, Lizet E van der Kolk, J Margriet Collée, Marijke R Wevers, Margreet G E M Ausems, Klaartje van Engelen, Irma van de Beek, Lieke P V Berger, Christi J van Asperen, Encarna B Gomez Garcia, Angela H E M Maas, Maartje J Hooning, Anneke B Steensma, Flora E van Leeuwen
Urinary incontinence more than 15 years after premenopausal risk-reducing salpingo-oophorectomy: a multicentre cross-sectional study. BJOG : an international journal of obstetrics and gynaecology (2023)
Malika Kengsakul, Gatske M Nieuwenhuyzen-de Boer, Suwasin Udomkarnjananun, Stephen J Kerr, H Lena C van Doorn, Heleen van Beekhuizen
Clinical validation and comparison of the Comprehensive Complication Index and Clavien-Dindo classification in predicting post-operative outcomes after cytoreductive surgery in advanced ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (2) (2023)
Nick J van de Berg, Franciscus P van Beurden, G C Wanda Wendel-Vos, Marjolein Duijvestijn, Heleen van Beekhuizen, Marianne Maliepaard, H Lena C van Doorn
Patient-Reported Mobility, Physical Activity, and Bicycle Use after Vulvar Carcinoma Surgery. Cancers 15 (8) (2023)
Nick J van de Berg, Franciscus P van Beurden, G C Wanda Wendel-Vos, Marjolein Duijvestijn, Heleen van Beekhuizen, Marianne Maliepaard, H Lena C van Doorn
Patient-Reported Mobility, Physical Activity, and Bicycle Use after Vulvar Carcinoma Surgery. Cancers 15 (8) (2023)
Iris A S Stroot, Jan Brouwer, Joost Bart, Harry Hollema, Denise J Stommel-Jenner, Marise M Wagner, H Lena C van Doorn, Joanne A de Hullu, Katja N Gaarenstroom, Marc Beurden, Luc R C W van Lonkhuijzen, Brigitte F M Slangen, Ronald P Zweemer, Encarna B Gómez-García, Margreet G E M Ausems, Ingrid A Boere, Klaartje van Engelen, Christi J van Asperen, Marjanka K Schmidt, Marijke R Wevers, Geertruida H de Bock, Marian J E Mourits, null null
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Anna J M van de Sande, Malika Kengsakul, Margot M Koeneman, M Jozwiak, Cornelis G Gerestein, Torben A Kruse, Edith M G van Esch, Peggy J de Vos van Steenwijk, Caroline L P Muntinga, Wichor M Bramer, H Lena C van Doorn, Folkert van Kemenade, Heleen van Beekhuizen
The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2023)
Malika Kengsakul, Gatske M Nieuwenhuyzen-de Boer, Suwasin Udomkarnjananun, Stephen J Kerr, H Lena C van Doorn, Heleen van Beekhuizen
Clinical validation and comparison of the Comprehensive Complication Index and Clavien-Dindo classification in predicting post-operative outcomes after cytoreductive surgery in advanced ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (2) (2023)
Gemma G Kenter, Stefano Greggi, Ignace Vergote, Dionyssios Katsaros, Juliusz Kobierski, H Lena C van Doorn, Fabio Landoni, Jacobus van der Velden, Nicholas Reed, Corneel Coens, Iske van Luijk, Nicoletta Colombo, Elzbietta van der Steen-Banasik, Petronella B Ottevanger, Antonio Casado Herraez, null null
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Gatske Nieuwenhuyzen-de Boer, Hanane Aamran, Caroline B van den Berg, Sten Willemsen, Jurgen M J Piek, Nathalie Reesink-Peters, Marianne Maliepaard, H Lena C van Doorn, Suzanne Polinder, Heleen van Beekhuizen
Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients. Cancers 15 (15) (2023)
Jasmijn Vaneman, Heleen van Beekhuizen, Joost L Boormans, Patricia C Ewing-Graham, G J L H Geert van Leenders, Ramon G V Smolders, H Lena C van Doorn
Pelvic lymph node dissection for cervical or bladder cancer: embedding residual fat tissue offers no added value. Virchows Archiv : an international journal of pathology (2023)
Gatske Nieuwenhuyzen-de Boer, Malika Kengsakul, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study. Cancers 15 (1) (2022)
Malika Kengsakul, Gatske M Nieuwenhuyzen-de Boer, Suwasin Udomkarnjananun, Stephen J Kerr, H Lena C van Doorn, Heleen van Beekhuizen
Clinical validation and comparison of the Comprehensive Complication Index and Clavien-Dindo classification in predicting post-operative outcomes after cytoreductive surgery in advanced ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)
Gatske Nieuwenhuyzen-de Boer, Malika Kengsakul, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study. Cancers 15 (1) (2022)
Gatske Nieuwenhuyzen-de Boer, Malika Kengsakul, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study. Cancers 15 (1) (2022)
Malika Kengsakul, Gatske Nieuwenhuyzen-de Boer, Suwasin Udomkarnjananun, Stephen J Kerr, H Lena C van Doorn, Heleen van Beekhuizen
Factors Predicting 30-Day Grade IIIa-V Clavien-Dindo Classification Complications and Delayed Chemotherapy Initiation after Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: A Prospective Cohort Study. Cancers 14 (17) (2022)
Lara Terra, Maartje J Hooning, Bernadette Anna Maria Heemskerk-Gerritsen, M van Beurden, Jeanine E Roeters van Lennep, H Lena C van Doorn, Joanne A de Hullu, Constantijne H Mom, Eleonora B L van Dorst, Marian J E Mourits, Brigitte F M Slangen, Katja N Gaarenstroom, M Carola Zillikens, Tim Leiner, Lizet van der Kolk, J Margriet Collée, Marijke R Wevers, Margreet G E M Ausems, Klaartje van Engelen, Lieke Pv Berger, Christi J van Asperen, Encarna B Gómez-García, Irma van de Beek, Matti A Rookus, Michael Hauptmann, Eveline M A Bleiker, Sanne B Schagen, Neil K Aaronson, Angela H E M Maas, Flora E van Leeuwen
Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study). JMIR research protocols 10 (1) (2021)
Ellis L Eikenboom, H Lena C van Doorn, Winand N M Dinjens, Hendrikus Jan Dubbink, Willemina R R Geurts-Giele, Manon C W Spaander, Carli M J Tops, Anja Wagner, Anne Goverde
Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers. Cancers 13 (3) (2021)
Anouk Corbeau, Remi A Nout, Jan Willem M Mens, Nanda Horeweg, Jérémy Godart, Ellen M Kerkhof, Sander C Kuipers, Mariette I E van Poelgeest, Judith R Kroep, Ingrid A Boere, H Lena C van Doorn, Mischa S Hoogeman, Uulke A van der Heide, Hein Putter, Marij J P Welters, Sjoerd H Van der Burg, Carien L Creutzberg, Stephanie M de Boer
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System. Cancers 13 (20) (2021)
Shatavisha Dasgupta, Senada Koljenović, Thierry P P van den Bosch, Sigrid M A Swagemakers, Nick M A van der Hoeven, Ronald van Marion, Peter J van der Spek, H Lena C van Doorn, Folkert J van Kemenade, Patricia C Ewing-Graham
Evaluation of Immunohistochemical Markers, CK17 and SOX2, as Adjuncts to p53 for the Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia (dVIN). Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Silvia R Vitale, Floris H Groenendijk, Ronald van Marion, Corine M Beaufort, Jean C Helmijr, Hendrikus Jan Dubbink, Winand N M Dinjens, Patricia C Ewing-Graham, Ramon Smolders, H Lena C van Doorn, Ingrid A Boere, Els M J J Berns, Jozien Helleman, Maurice P H M Jansen
TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer. Biomolecules 10 (3) (2020)
Heleen van Beekhuizen, Mieloe D Freulings, Shatavisha Dasgupta, Folkert van Kemenade, Patricia C Ewing-Graham, H Lena C van Doorn
Relevance of routine pathology review in cervical carcinoma. Virchows Archiv : an international journal of pathology 477 (2) (2020)
Marline G Harmsen, Miranda P Steenbeek, Nicoline Hoogerbrugge, H Lena C van Doorn, Katja N Gaarenstroom, Maria Caroline Vos, Leon F A G Massuger, Joanne A de Hullu, Rosella P M G Hermens
A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing. Health expectations : an international journal of public participation in health care and health policy 21 (3) (2017)